Stock Market News3 weeks BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant Zacks
BIIB’s TRANSCEND phase III study on felzartamab in adult kidney transplant recipients diagnosed with late AMR is set to enroll approximately 120 patients.
X3 days Biogen: Balancing Risks And Opportunities Seeking Alpha
X2 weeks Biogen Inc. (BIIB) Stifel 2025 Virtual CNS Forum Conference (Transcript) Seeking Alpha
X2 weeks Why Is Biogen (BIIB) Up 1.1% Since Last Earnings Report? Zacks
X2 weeks Can BIIB’s New Drugs Revive Growth as Multiple Sclerosis Sales Fall? Zacks
X3 weeks Biogen Inc. (BIIB) Management presents at Leerink Global Healthcare Conference 2025 (Transcript) Seeking Alpha
X3 weeks The Nasdaq is Cratering But REGN, BIIB and CSGP Are Up Big Today 24/7 Wall St.
X4 weeks Biogen Inc. (BIIB) CEO Chris Viehbacher presents at TD Cowen 45th Annual Health Care Conference (Transcript) Seeking Alpha
X1 month Stoke Therapeutics and Biogen in pact for treatment for severe form of childhood epilepsy MarketWatch
X1 month Biogen Q4 Earnings Review: Why I’m Calling Time On This ‘Powder Puff’ Pharma Seeking Alpha
X1 month Biotech Stock Roundup: GILD Up on Q4 Results, BIIB, BMY Down on 2025 Guidance Zacks
X2 months Biogen’s Q4 Earnings & Sales Beat, 2025 EPS Guidance Disappoints Zacks
X2 months Biogen Stock Falls After Company Gives Weaker-Than-Expected Financial Outlook Yahoo Finance
X2 months Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma Yahoo Finance
X2 months Biogen (BIIB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates Zacks
X2 months Biogen Inc. 2024 Q4 – Results – Earnings Call Presentation Seeking Alpha
X2 months Drugmaker Biogen forecasts 2025 profit below expectations Yahoo Finance
X2 months Biogen Hammered As Lackluster Guidance Drags On Fourth-Quarter Beat Investor's Business Daily
X2 months Bernstein starts Biogen at ‘market-perform,’ notes near term uncertainty Investing.com
X2 months Biogen Gears Up to Report Q4 Earnings: What’s in the Cards? Zacks
X2 months Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth Zacks
X2 months Biogen Stock Down on Regulatory Update in the EU for Alzheimer’s Drug Zacks
X2 months The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics Zacks
X2 months Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report? Zacks
X2 months Biotech Stock Roundup: SAGE Up on Declining BIIB’s Offer, CYTK, AKRO Up on Updates Zacks
X2 months SAGE Rejects Biogen’s Offer to Buy Remaining Stake, Stock Up Zacks
XThe Stock Market News
The Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.